Viewing Study NCT02086968


Ignite Creation Date: 2025-12-24 @ 5:32 PM
Ignite Modification Date: 2025-12-24 @ 5:32 PM
Study NCT ID: NCT02086968
Status: COMPLETED
Last Update Posted: 2020-09-17
First Post: 2014-03-12
Is Possible Gene Therapy: False
Has Adverse Events: True

Brief Title: Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass
Sponsor: American Regent, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 1VIT13035
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators